Morgan Stanley Reiterates Underweight on Bed Bath & Beyond (BBBY) Following 4Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Six killed in cyclone off India's eastern coast
- Qualcomm shares fall on Intel warning and legal concerns
- Amazon (AMZN) Misses Q3 EPS by 7c, Misses on Revenue; Offers Q4 Revenue Guidance
- Sandisk announces 8-for-1 forward stock split effective November 2026
- Reddit, Inc. (RDDT) Tops Q3 EPS by 7c, Beats on Revenue; Offers Q4 Revenue Guidance
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Pre-Open Stock Movers 04/07: (SUNE) (ICPT) (OLLI) (VRX) Higher; (ALDR) (TWTR) (YHOO) Lower (more...)
April 7, 2016 9:32 AM EDTToday's pre-open stock movers:
SunEdison (NYSE: SUNE) 12% HIGHER; adds to recent gains
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) 11.8% HIGHER; gained ahead of today's FDA AdCom; currently halted.
Ollie's Bargain Outlet (NASDAQ: OLLI) 11% HIGHER; reported Q4 EPS of $0.31, $0.03 better than the analyst estimate of $0.28. Revenue for the quarter came in at $243.4 million... More
UBS Remains Sidelined on Bed Bath & Beyond (BBBY) Following 4Q Results
April 7, 2016 9:02 AM EDTUBS reiterated a Neutral rating and $52.00 price target on Bed Bath & Beyond (NASDAQ: BBBY) following the company's 4Q earnings report. 4Q EPS of $1.85 exceeded the consensus forecast. BBBY also reported comps of 1.7%, beating street estimates of 0.8%.
Analyst Michael Las commented, "The company's 1.7% comp beat our forecast of... More
Nomura Securities Remains Sidelined on Bed Bath & Beyond (BBBY) Following 4Q Results
April 7, 2016 8:26 AM EDTNomura Securities reiterated a Neutral rating and $50.00 price target on Bed Bath & Beyond (NASDAQ: BBBY) following the company's 4Q earnings report. BBBY reported 4Q EPS of $1.91, better than consensus estimates. Nomura lowered 2016 and 2017 EPS estimates to $5.00 and $5.30 from $5.15 and $5.35, respectively.
Analyst Jessica Mace... More
Wedbush Remains Sidelined on Bed Bath & Beyond (BBBY) Following 4Q Beat
April 7, 2016 8:01 AM EDTWedbush reiterated a Neutral rating and $46.00 price target on Bed Bath & Beyond (NASDAQ: BBBY) following the company's 4Q earnings report. BBBY reported 4Q adjusted EPS of $1.85, beating consensus expectations of $1.80.
Analyst Seth Basham commented, "Although quality was not superb with gross margins... More
After-Hours Stock Movers 04/06: (OLLI) (APOG) (VRX) Higher; (RPTP) (ALDR) (EBAY) Lower (more...)
April 6, 2016 6:09 PM EDTOllie's Bargain Outlet (NASDAQ: OLLI) 5.7% HIGHER; reported Q4 EPS of $0.31, $0.03 better than the analyst estimate of $0.28. Revenue for the quarter came in at $243.4 million versus the consensus estimate of $239.06 million. Comparable store sales increased 5.0%.
Raptor Pharmaceuticals Corp. (NASDAQ: RPTP) 4.5% LOWER; gives back some intra-day gains... More
Bed Bath & Beyond (BBBY) Initiates Qtr. Dividend at 12.5c/Share; Yields 1%
April 6, 2016 4:18 PM EDTBed Bath & Beyond (NASDAQ: BBBY) initiates a quarterly dividend of $0.125 per share, or $0.5 annualized.
The dividend will be payable on July 19, 2016, to stockholders of record on June 17, 2016, with an ex-dividend date of June 15, 2016.
The annual yield on the dividend is 1... More
Bed Bath & Beyond (BBBY) Tops Q4 EPS Views; Initiates Quarterly Dividend
April 6, 2016 4:17 PM EDTBed Bath & Beyond (Nasdaq: BBBY) reported Q4 EPS of $1.85, $0.04 better than the analyst estimate of $1.81. Revenue for the quarter came in at $3.42 billion versus the consensus estimate of $3.39 billion.
EPS excluded approximately $0.06 per diluted share of a net benefit for certain non-recurring items,... More



